Shire Opens New Front In Carbatrol Litigation

Law360, New York (May 18, 2006, 12:00 AM EDT) -- Shire Laboratories Inc. has filed a patent infringement lawsuit against generic drug maker Corepharma LLC, accusing the company of infringing patents for its lucrative, number-three drug Carbatrol, a treatment for seizure disorders.

The complaint, filed in the U.S. District Court for the District of New Jersey, was a response to Corepharma’s Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration and represents the second such battle Shire has initiated over the drug.

Corepharma’s ANDA, filed in April, requested permission to manufacture generic versions...
To view the full article, register now.